Aurobindo Pharma trades with traction on the bourses

11 Aug 2017 Evaluate

Aurobindo Pharma is currently trading at Rs. 697.75, up by 14.75 points or 2.16% from its previous closing of Rs. 683.00 on the BSE.

The scrip opened at Rs. 679.95 and has touched a high and low of Rs. 703.10 and Rs. 670.80 respectively. So far 134622 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 895.00 on 06-Oct-2016 and a 52 week low of Rs. 504.00 on 29-May-2017.

Last one week high and low of the scrip stood at Rs. 740.95 and Rs. 666.25 respectively. The current market cap of the company is Rs. 40030.42 crore.

The promoters holding in the company stood at 51.87%, while institutions and non-institutions held 33.81% and 14.32% respectively.

Aurobindo Pharma has entered into agreement to acquire 20% additional equity stake in Tergene Biotech. As agreed among the JV Partners, the company will increase its stake in Tergene Biotech from 60% to 80% by subscribing additional 56,50,000 equity shares of Rs 10 each at par aggregating to Rs 5.65 crore. As on date, the company acquired 3.25% and will continue to acquire balance 16.75% over a period of time.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.

Aurobindo Pharma Share Price

1130.75 6.00 (0.53%)
08-May-2024 11:48 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1520.15
Dr. Reddys Lab 6043.45
Cipla 1390.65
Zydus Lifesciences 1001.50
Lupin 1610.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.